|
ZNF238 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7723600365116E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32499999971891E-07 |
| Normal-vs-Stage2 |
1.283920E-02 |
| Normal-vs-Stage3 |
2.464100E-02 |
| Normal-vs-Stage4 |
1.186570E-01 |
| Stage1-vs-Stage2 |
7.568400E-01 |
| Stage1-vs-Stage3 |
9.631600E-01 |
| Stage1-vs-Stage4 |
1.996020E-01 |
| Stage2-vs-Stage3 |
7.882000E-01 |
| Stage2-vs-Stage4 |
2.466200E-01 |
| Stage3-vs-Stage4 |
3.864000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.08928446660184E-12 |
| Normal-vs-AfricanAmerican |
8.637500E-04 |
| Normal-vs-Asian |
6.168200E-01 |
| Caucasian-vs-AfricanAmerican |
3.201600E-02 |
| Caucasian-vs-Asian |
6.101900E-03 |
| AfricanAmerican-vs-Asian |
1.542430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27842222655772E-12 |
| Normal-vs-Female |
7.90270000000648E-05 |
| Male-vs-Female |
4.206400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.178480E-02 |
| Normal-vs-Extreme_Weight |
6.11750000000244E-05 |
| Normal-vs-Obese |
1.55396999999002E-05 |
| Normal-vs-Extreme_Obese |
1.242480E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.634600E-01 |
| Normal_Weight-vs-Obese |
1.531620E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.597700E-02 |
| Extreme_Weight-vs-Obese |
1.126170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.846200E-02 |
| Obese-vs-Extreme_Obese |
4.196200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.740000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.05100039782258E-10 |
| Normal-vs-Age(61-80Yrs) |
9.20389999992111E-07 |
| Normal-vs-Age(81-100Yrs) |
2.311000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.805200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.154800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.020400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.591200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.836000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.77635683940025E-15 |
| Normal-VS-Type2 PRCC |
6.357600E-02 |
| Normal-VS-KIRP CIMP |
4.785400E-01 |
| Normal-VS-Unclassified PRCC |
4.145000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.172400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.792000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.728210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.813200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.396800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.765000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.797300E-03 |
| Normal-vs-N1 |
8.226400E-02 |
| Normal-vs-N2 |
2.059200E-01 |
| N0-vs-N1 |
4.123000E-01 |
| N0-vs-N2 |
8.737700E-02 |
| N1-vs-N2 |
6.594600E-01 |
|
|
